NCT00242372 GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin Status TERMINATED Phase PHASE3
NCT00241423 Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00240253 A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00232362 Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus Status WITHDRAWN Phase PHASE1
NCT00231725 Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin Status COMPLETED Phase PHASE3
NCT00229658 An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes Status COMPLETED Phase N/A
NCT00213122 Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin Status COMPLETED Phase PHASE3
NCT00213070 Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment Status COMPLETED Phase PHASE3
NCT00212290 Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00207389 A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients Status TERMINATED Phase N/A
NCT00207233 Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00205660 Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Status COMPLETED Phase PHASE4
NCT00198913 Long Term Free Living Study With Modified Foods and Type 2 Diabetics Status COMPLETED Phase NA
NCT00198757 Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures Status COMPLETED Phase NA